Search images on Google      Product Monograph

Active Ingredients:

• bortezomib (bortezomib mannitol boronic ester), 3.5 MG/VIAL

DIN: 02452456

Dosage Form(s): POWDER FOR SOLUTION

Route(s) of Administration: INTRAVENOUS, SUBCUTANEOUS

Description: SINGLE USE VIAL

Schedule: Prescription

Company: DR REDDY'S LABORATORIES LTD

ATC:

• L01 - ANTINEOPLASTIC AGENTS (ATC, WHO, Wiki)
• L01X - OTHER ANTINEOPLASTIC AGENTS (ATC, WHO)
• L01XG - (ATC, WHO)
• L01XG01 - BORTEZOMIB (WHO)

Packaging:

• Package size unit: No information
• Package type: No information
• Package size: No information
• Product information: SC: 1.4ML (2.5MG/ML) / IV: 3.5ML (1MG/ML)

Pharmaceutical standard: MFR

 

External Links for Bortezomib For Injection:

Search on Google

• Bortezomib For Injection side effects
• Bortezomib For Injection dosage
• bortezomib side effects
• bortezomib dosage